Inositol

insulin ; Homo sapiens







178 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
101 24501149 Hyperinsulinemia Alters Myoinositol to d-chiroinositol Ratio in the Follicular Fluid of Patients With PCOS. 2014 Jul 1
102 24505965 [The role of inositol deficiency in the etiology of polycystic ovary syndrome disorders]. 2014 Jan 2
103 24601829 Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients. 2014 Jun 2
104 24606639 Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome. 2014 May 2
105 24614687 Insights into the pathophysiology of catch-up compared with non-catch-up growth in children born small for gestational age: an integrated analysis of metabolic and transcriptomic data. 2014 Aug 1
106 24876842 The Efficacy of Inositol and N-Acetyl Cysteine Administration (Ovaric HP) in Improving the Ovarian Function in Infertile Women with PCOS with or without Insulin Resistance. 2014 1
107 24898153 Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome. 2014 Sep 1
108 25010620 Inositol: history of an effective therapy for Polycystic Ovary Syndrome. 2014 Jul 4
109 25042908 The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome. 2014 Oct 3
110 25054962 [Myo-inositol in the treatment of polycystic ovary syndrome]. 2014 Jun 3
111 25245999 Resveratrol, inositol, vitamin D and K in the prevention of cardiovascular and osteoporotic risk: a novel approach in peri- and postmenopause. 2014 Oct 1
112 25373012 [Combination inositol and glucomannan in PCOS patients]. 2014 Dec 2
113 23336594 Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study. 2013 Apr 1
114 23412023 [Evaluation of the myo-inositol-monacolin K association on hyperandrogenism and on the lipidic metabolism parameters in PCOS women]. 2013 Feb 2
115 23467955 The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients. 2013 Feb 2
116 23596182 The effect of insulin infusion on the metabolites in cerebral tissues assessed with proton magnetic resonance spectroscopy in young healthy subjects with high and low insulin sensitivity. 2013 Sep 3
117 23764390 Potential role and therapeutic interests of myo-inositol in metabolic diseases. 2013 Oct 7
118 23981814 Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo-controlled trial. 2013 Aug 28 3
119 24219712 Myoinositol: a new marker of intrauterine growth restriction? 2013 Nov 2
120 22192068 One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome. 2012 Oct 1
121 22587479 CONCERN: Does ovary need D-chiro-inositol? 2012 May 15 1
122 22592687 Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. 2012 May 16 1
123 22612517 Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients. 2012 Dec 4
124 23232537 [Evaluation of the treatment with D-chiro-inositol on levels of oxidative stress in PCOS patients]. 2012 Dec 1
125 20587749 Deletion of Nck1 attenuates hepatic ER stress signaling and improves glucose tolerance and insulin signaling in liver of obese mice. 2011 Mar 2
126 20811299 Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 2011 Jan 1
127 20814537 Metabolomics reveals relationship between plasma inositols and birth weight: possible markers for fetal programming of type 2 diabetes. 2011 2
128 21300338 The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen. 2011 Jun 30 2
129 21414183 The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 2011 Aug 5
130 21514580 The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen. 2011 Jun 30 1
131 21845803 Inositol safety: clinical evidences. 2011 Aug 1
132 22452173 [Myoinositol--alternative treatment of insulin resistance in adolescents]. 2011 3
133 20091537 Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. 2010 Jan 20 1
134 20156067 Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndrome. 2010 Apr 3
135 19059532 Hyperinsulinemia is closely related to low urinary clearance of D-chiro-inositol in men with a wide range of insulin sensitivity. 2009 Jan 1
136 19492925 Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes mellitus. 2009 2
137 19499845 Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. 2009 Mar-Apr 2
138 19551544 Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome. 2009 Aug 1
139 19800728 Contribution of myo-inositol to reproduction. 2009 Dec 2
140 19821299 Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. 2009 Oct 7 1
141 18335328 Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. 2008 Mar 1
142 18375940 Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism. 2008 Jun 1
143 18609357 Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: a multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension. 2008 Aug 1
144 18803944 Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome. 2008 Oct 3
145 18940392 Relationships between urinary inositol excretions and whole-body glucose tolerance and skeletal muscle insulin receptor phosphorylation. 2008 Nov 3
146 17116762 Inositol phosphoglycan P-type in preeclampsia: a novel marker? 2007 Jan 1
147 17537518 Preeclampsia, insulin signalling and immunological dysfunction: a fetal, maternal or placental disorder? 2007 Dec 2
148 17664885 Altered urinary release of inositol phosphoglycan A-type in women with gestational diabetes mellitus. 2007 1
149 17952759 Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. 2007 Dec 2
150 16443877 Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome. 2006 Feb 1